Actively Recruiting
Establish Diagnostic Models Based on Portal Venous Blood for Pancreatic Cancer
Led by Changhai Hospital · Updated on 2024-03-29
300
Participants Needed
1
Research Sites
134 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Explore new markers based on portal venous blood sampling to establish novel diagnostic models for identification of malignant pancreatic mass.
CONDITIONS
Official Title
Establish Diagnostic Models Based on Portal Venous Blood for Pancreatic Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 to 75 years, male or female
- Diagnosis or suspicion of solid pancreatic mass based on previous imaging (ultrasonography, CT, or MRI)
- Lesion diameter larger than 1 cm
- Signed informed consent letter
You will not qualify if you...
- Pregnant female
- Pancreatic cystic lesions
- Anticoagulant or antiplatelet therapy that cannot be stopped
- Unable or refuse to provide informed consent
- Coagulopathy (platelet count < 50�d7 10^3/bcL, international normalized ratio > 1.5)
- Severe cardiopulmonary dysfunction intolerant to intravenous anesthesia
- History of mental disease
- Other medical conditions not suitable for EUS-FNA
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Changhai Hospital
Shanghai, Shanghai Municipality, China, 200433
Actively Recruiting
Research Team
X
Xiangyu Kong, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here